Historique
Drug Testing and Analysis, Vol.17, n°3. - March 2025
| Titre : | Drug Testing and Analysis, Vol.17, n°3. - March 2025 |
| Type de document : | Bulletin |
| Paru le : | 01/03/2025 |
Dépouillements
Ajouter le résultat à votre sélection
Nouveauté
S. KILLORAN ;
S. McNAMARA ;
P. KAVANAGH ;
J. O'BRIEN ;
R. LAKES
|
2025
Dans Drug Testing and Analysis (Vol.17, n°3, March 2025) Article : Périodique
Dans Drug Testing and Analysis (Vol.17, n°3, March 2025) Article : Périodique
Synthetic opioids have been associated globally with adverse effects in drug users. The nitazene group of drugs is a relatively new addition to the synthetic opioid class emerging in Europe in 2019. Some nitazenes have been shown to be more pote[...]
Nouveauté
K. LINDBOM ;
C. NORMAN ;
S. BAGINSKI ;
L. KREBS ;
D. STALBERGA ;
T. RAUTIO ;
X. WU ;
R. KRONSTRAND ;
H. GREEN
|
2025
Dans Drug Testing and Analysis (Vol.17, n°3, March 2025) Article : Périodique
Dans Drug Testing and Analysis (Vol.17, n°3, March 2025) Article : Périodique
Hexahydrocannabinol (HHC), hexahydrocannabiphorol (HHCP) and their acetates, HHC-O and HHCP-O, respectively, are emerging in Europe as alternatives to tetrahydrocannabinol (THC). This study aimed to elucidate the metabolic pathways of the semi-s[...]